drugset / Trial / NCT01276821
Efficacy of Nebulised Hypertonic Saline (3%) Among Children With Bronchiolitis.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To assess the efficacy of nebulized 3% hypertonic saline in improving clinical severity scores among children aged 6 weeks to 24 months with bronchiolitis.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hypertonic saline | Unknown | 4 ml | Inhaled |
| Comparator | Epinephrine | Other / unclassified | 1.5 mg | Inhaled |